Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.95 - $1.5 $6,849 - $10,815
-7,210 Reduced 67.92%
3,405 $3,000
Q4 2023

Feb 09, 2024

BUY
$0.92 - $1.6 $9,765 - $16,984
10,615 New
10,615 $11,000
Q2 2023

Aug 11, 2023

BUY
$2.99 - $4.15 $1,369 - $1,900
458 New
458 $1,000
Q4 2022

Feb 08, 2023

BUY
$4.26 - $5.22 $12,707 - $15,571
2,983 New
2,983 $13,000
Q2 2022

Aug 10, 2022

SELL
$4.1 - $7.36 $2,689 - $4,828
-656 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$6.64 - $8.21 $5,810 - $7,183
-875 Reduced 57.15%
656 $5,000
Q4 2021

Feb 14, 2022

BUY
$6.57 - $9.78 $6,478 - $9,643
986 Added 180.92%
1,531 $11,000
Q3 2021

Nov 15, 2021

SELL
$8.85 - $12.5 $66,401 - $93,787
-7,503 Reduced 93.23%
545 $5,000
Q2 2021

Aug 13, 2021

BUY
$9.53 - $14.7 $74,858 - $115,468
7,855 Added 4069.95%
8,048 $100,000
Q1 2021

May 12, 2021

BUY
$8.75 - $15.49 $1,522 - $2,695
174 Added 915.79%
193 $2,000
Q4 2020

Feb 11, 2021

SELL
$7.11 - $9.99 $57,399 - $80,649
-8,073 Reduced 99.77%
19 $0
Q3 2020

Nov 12, 2020

BUY
$7.15 - $8.73 $45,874 - $56,011
6,416 Added 382.82%
8,092 $59,000
Q2 2020

Jul 31, 2020

BUY
$6.15 - $9.4 $8,517 - $13,019
1,385 Added 475.95%
1,676 $15,000
Q1 2020

May 01, 2020

SELL
$5.88 - $15.75 $4,168 - $11,166
-709 Reduced 70.9%
291 $2,000
Q4 2019

Feb 14, 2020

SELL
$7.5 - $17.15 $6,585 - $15,057
-878 Reduced 46.75%
1,000 $17,000
Q3 2019

Nov 14, 2019

SELL
$7.7 - $10.48 $1,478 - $2,012
-192 Reduced 9.28%
1,878 $17,000
Q2 2019

Aug 14, 2019

SELL
$6.78 - $9.49 $7,451 - $10,429
-1,099 Reduced 34.68%
2,070 $19,000
Q1 2019

May 14, 2019

BUY
$5.71 - $7.19 $5,710 - $7,190
1,000 Added 46.1%
3,169 $22,000
Q4 2018

Feb 14, 2019

SELL
$5.79 - $8.1 $7,474 - $10,457
-1,291 Reduced 37.31%
2,169 $13,000
Q3 2018

Nov 14, 2018

BUY
$6.2 - $7.8 $2,442 - $3,073
394 Added 12.85%
3,460 $26,000
Q2 2018

Aug 14, 2018

BUY
$7.5 - $10.71 $15,495 - $22,126
2,066 Added 206.6%
3,066 $24,000
Q1 2018

May 15, 2018

BUY
$10.3 - $13.64 $10,300 - $13,640
1,000 New
1,000 $10,000

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $15M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.